Drugs / iDC
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 1/2 | NCT01947569 | Oct 2013 → Nov 2014 | type 1 diabetes mellitus | DiaVacs, Inc. | Unknown | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | iDC | “iDC cells modified by in vitro engineering.” NCT01947569 ↗ |
| Modality | Cell therapy | “iDC cells modified by in vitro engineering.” NCT01947569 ↗ |